Establishing A Blood-based Biomarker Panel For Pre-clinical Alzheimer’s Disease
Funder
National Health and Medical Research Council
Funding Amount
$716,778.00
Summary
The current gold standard biomarkers for Alzheimer’s disease (AD) are uneconomical and invasive, thus impeding early treatment prior to irreversible damage. I posit that biochemical changes associated with the disease are reflected in the blood several years prior to the clinical manifestation of the disease. Therefore, I propose to investigate these changes in individuals predisposed to AD, prior to the appearance of clinical symptoms, to identify biomarkers for the early diagnosis of AD.
Aberrant Nerve Excitability: An In-depth Study Of HCN Channel Activity In Neurological Disorders (epilepsy And Chronic Neuropathic Pain).
Funder
National Health and Medical Research Council
Funding Amount
$205,315.00
Summary
Chronic neuropathic pain and epilepsy carry a high burden of disease, and have a major impact on health resources. Abnormal nerve excitability is implicated in both conditions. This study evaluates the use of a non-invasive test applied to peripheral nerve in the measurement of nerve excitability in neuropathic pain and epilepsy. The aim is to establish a sensitive biomarker of disease in assessment and diagnosis of patients, and to help direct therapy and measure response to treatment.
Predicting Perioperative Cognitive Disorders In The Elderly Based On Cardiovascular Risk, AD Risk And New Biomarkers
Funder
National Health and Medical Research Council
Funding Amount
$471,826.00
Summary
Anaesthesia and surgery are common in the elderly and are known to lead to memory and thinking problems. Why this happens is unclear. I plan to study confusion, memory and thinking problems before and after surgery and to determine if blood or cerebrospinal fluid tests or modifying cardiovascular disease can predict this happening. This work will lead to early identification of people who are at risk of cognitive problems following anaesthesia and surgery, and ways to prevent this happening.
Discovery And Validation Of Alzheimer�s Disease Biomarkers In Human Plasma
Funder
National Health and Medical Research Council
Funding Amount
$365,126.00
Summary
With life expectancy increasing Alzheimer�s disease (AD) poses a rising medical and socioeconomic challenge, emphasising the need for the development of prevention and treatment strategies. Such strategies will be most effective if administered early in the disease process, making early diagnosis critical to their success. The identification of biomarkers in this project, which are altered during the development of AD, will lead to the development of such a means to diagnosis AD at an early stag ....With life expectancy increasing Alzheimer�s disease (AD) poses a rising medical and socioeconomic challenge, emphasising the need for the development of prevention and treatment strategies. Such strategies will be most effective if administered early in the disease process, making early diagnosis critical to their success. The identification of biomarkers in this project, which are altered during the development of AD, will lead to the development of such a means to diagnosis AD at an early stage, when interventions will have the most impact.Read moreRead less
A Randomised Clinical Trial Of Physical Activity To Delay The Progression Of Cerebrovascular Pathology
Funder
National Health and Medical Research Council
Funding Amount
$654,613.00
Summary
The aim of this randomised clinical trial is to establish whether a 24 months physical activity (PA) program for older adults with memory problems can delay the progression of damage to the blood vessel system in the brain, measured on an MRI scan. It also will investigate whether cognition, mood, quality of life, functional level, fitness and biological markers will improve with the intervention. If successful this PA program could become part of clinical care for adults at risk of dementia.